BLT Share Price

Open 0.14 Change Price %
High 0.15 1 Day 0.01 7.69
Low 0.14 1 Week 0.02 16.67
Close 0.14 1 Month 0.05 55.56
Volume 1099790 1 Year -0.16 -53.33
52 Week High 0.30
52 Week Low 0.08
BLT Important Levels
Resistance 2 0.15
Resistance 1 0.15
Pivot 0.14
Support 1 0.13
Support 2 0.13
ASX Australia Most Active Stocks
AGO 0.04 0.00%
AGO 0.04 0.00%
AGO 0.04 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
DUE 2.93 5.40%
DUE 2.93 5.40%
DJS 3.99 0.00%
DJS 3.99 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
PMQ 0.03 50.00%
VMS 0.03 50.00%
VMS 0.03 50.00%
MMR 0.03 50.00%
MMR 0.03 50.00%
MMR 0.03 50.00%
PVE 0.03 50.00%
TKL 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
DDT 0.01 -50.00%
GDY 0.01 -50.00%
RHT 0.02 -33.33%
RHT 0.02 -33.33%
POH 0.02 -33.33%
More..

Benitec Biopharma Ltd (ASX: BLT)

BLT Technical Analysis 4
As on 16th Jan 2017 BLT Share Price closed @ 0.14 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.12 & Strong Buy for SHORT-TERM with Stoploss of 0.11 we also expect STOCK to react on Following IMPORTANT LEVELS.
BLT Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
BLT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.benitec.com
BLT Address
BLT
Level 16
356 Collins Street
Melbourne, VIC 3000
Australia
Phone: 61 2 9555 6986
Fax: 61 3 8678 1342
BLT Latest News
Update on Valuation Formula's For Benitec Biopharma Limited (ASX:BLT)   Marion Business Daily   - 04th Jan 17
Wonder Stock in the News: Penny Stock Investors Looking at Benitec Biopharma ...   Duncan Research   - 03rd Jan 17
Investors Pocketing Gains Last Half of Year in Benitec Biopharma Limited (:BNTC)   Engelwood Daily   - 02nd Jan 17
BRIEF-Benitec Biopharma says commenced strategic engagement with Nantventu...   Reuters   - 24th Oct 16
Benitec Biopharma Ltd has Hepatitis B success with treatment   Proactive Investors Australia   - 08th Mar 16
Why Benitec Biopharma Limited (ADR) (BNTC) got downgraded?   CWRU Observer   - 29th Feb 16
Benitec Biopharma readies to raise cash   Proactive Investors Australia   - 18th Aug 15
DOW JONES, A NEWS CORP COMPANY   Wall Street Journal   - 01st Aug 15
PEG Ratio (5 yr expected):   Yahoo!7 News   - 29th Mar 14
Benitec Biopharma Ltd.   MarketWatch   - 27th Aug 11
Interactive Technical Analysis Chart Benitec Biopharma Ltd ( BLT ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Benitec Biopharma Ltd
BLT Business Profile
Benitec Biopharma Limited, a biotechnology company, develops novel treatments for chronic and life-threatening conditions based on its gene silencing technology, DNA-directed RNA interference (ddRNAi). The company’s ddRNAi technology provides novel therapeutics to treat a range of human medical diseases and conditions, such as hepatitis C, hepatitis B, wet age-related macular degeneration, cancer-associated pain, drug resistant lung cancer, and oculopharyngeal muscular dystrophy (OPMD). Its pipeline of in-house and partnered therapeutic programs include TT-034 for hepatitis C; Tribetarna for the treatment of chemotherapy resistant non-small cell lung cancer; Nervarna to treat chronic cancer-associated pain; Hepbarna for Hepatitis B; and Pabparna for the treatment of OPMD. The company also licenses its ddRNAi technology to biopharmaceutical companies for the clinical applications comprising HIV/AIDS, retinitis pigmentosa, and Huntington’s disease. Benitec Biopharma Limited was founded in 1997 and is based in Sydney, Australia.